Hi-Tech Pharmacal Announces Agreement with Diabetic.com
AMITYVILLE, N.Y., Jun 26, 2000 (BUSINESS WIRE) -- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK chart, msgs) announced today that it has signed a co-marketing Agreement with Diabetic.com, a leading website dedicated to the special needs of individuals with diabetes. This major informational and educational Internet site, launched about a year ago, has rapidly grown in popularity with consumers and currently receives over 500,000 visits a month.
According to the Agreement, Diabetic.com will actively promote and feature Diabetic Tussin, DiabetiDerm, and DiabetiGest, the major products manufactured by Healthcare Products, a division of HITK. Special attention will be paid to DiabetiSweet, a new and unique sweetener for people with diabetes that can be used for cooking and baking. At the same time, HITK's websites will provide links to Diabetic.com.
Commenting on the Agreement, David Seltzer, President & CEO of HITK said, "We view the partnership with Diabetic.com as a very important step in implementing our Internet Strategy for the Diabetic Product line announced in April 2000. This Agreement will give HITK's products unique exposure at a major Internet site designed to improve health and lifestyle of people with diabetes. We believe the Internet is a very efficient means of educating and reaching out to millions of people with diabetes. The Internet successfully complements our nationwide distribution. Establishing cross links between Diabetic.com site and HITK's own sites diabeticproducts.com and diabetisweet.com, will further strengthen wide consumer awareness of our product line and we believe, may lead to higher sales and profits for the company."
Hi-Tech Pharmacal is a specialty pharmaceutical manufacturer of branded and generic prescription and over-the-counter and nutritional products for the general healthcare industry. A specialist in liquid and semi-solid dosage form production, Hi-Tech Pharmacal markets a broad line of generic products under the "H-T" and "Rx Choice" labels, and serves as a contract manufacturer and marketer of otic and inhalation products.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in the company's filings with the Securities and Exchange Commission, copies of which are available from the company. |
